These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11475387)

  • 1. Does cost-effectiveness analysis make a difference? Lessons from Pap smears. Symposium.
    Hagen MD; Garber AM; Goldie SJ; Lafata JE; Mandelblatt J; Meltzer D; Neumann P; Siegel JE; Sox HC; Tsevat J
    Med Decis Making; 2001; 21(4):307-23. PubMed ID: 11475387
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of methods to enhance sensitivity of Papanicolaou testing.
    Leidy NK; Brown R; Luce B; Sheets E
    JAMA; 1999 Oct; 282(15):1419; author reply 1420. PubMed ID: 10535423
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of methods to enhance sensitivity of Papanicolaou testing.
    Sedlacek TV
    JAMA; 1999 Oct; 282(15):1419-20. PubMed ID: 10535424
    [No Abstract]   [Full Text] [Related]  

  • 4. The utility and cost-effectiveness of Pap test rescreening.
    Raab SS
    Clin Lab Manage Rev; 1998; 12(2):91-6. PubMed ID: 10178714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pap smears, elderly women, and Medicare.
    Power EJ
    Cancer Invest; 1993; 11(2):164-8. PubMed ID: 8462016
    [No Abstract]   [Full Text] [Related]  

  • 6. The cost-effectiveness of screening programs using single and multiple birth cohort simulations: a comparison using a model of cervical cancer.
    Dewilde S; Anderson R
    Med Decis Making; 2004; 24(5):486-92. PubMed ID: 15358997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescreening of cervical Papanicolaou smears using PAPNET.
    Schechter CB
    JAMA; 1998 Jun; 279(22):1787; author reply 1787-8. PubMed ID: 9628708
    [No Abstract]   [Full Text] [Related]  

  • 8. Rescreening of cervical Papanicolaou smears using PAPNET.
    Mango LJ; Radensky PW
    JAMA; 1998 Jun; 279(22):1786-7; author reply 1787-8. PubMed ID: 9628707
    [No Abstract]   [Full Text] [Related]  

  • 9. Pap smears are financially undervalued in the United States.
    Herbert A
    Hum Pathol; 1997 Oct; 28(10):1218. PubMed ID: 9343333
    [No Abstract]   [Full Text] [Related]  

  • 10. Should we abandon pap smear testing?
    DeMay RM
    Am J Clin Pathol; 2000 Nov; 114 Suppl():S48-51. PubMed ID: 11996169
    [No Abstract]   [Full Text] [Related]  

  • 11. The cost-effectiveness of cervical cancer screening for low-income elderly women.
    Mandelblatt JS; Fahs MC
    JAMA; 1988 Apr 22-29; 259(16):2409-13. PubMed ID: 3127608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current status of the Papanicolaou smear.
    Shingleton HM; Patrick RL; Johnston WW; Smith RA
    CA Cancer J Clin; 1995; 45(5):305-20. PubMed ID: 7656133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.
    Kim JJ; Leung GM; Woo PP; Goldie SJ
    J Public Health (Oxf); 2004 Jun; 26(2):130-7. PubMed ID: 15284314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of cervical cancer prevention.
    Esselen KM; Feldman S
    Clin Obstet Gynecol; 2013 Mar; 56(1):55-64. PubMed ID: 23318570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paying for prevention standardizing the measurement of the value of health care interventions.
    Vasilev SA
    Obstet Gynecol Clin North Am; 2002 Dec; 29(4):613-43, v. PubMed ID: 12509088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing.
    Brown AD; Garber AM
    JAMA; 1999 Jan; 281(4):347-53. PubMed ID: 9929088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for cervical cancer: 1982--an update.
    Creasman WT; Fowler WC; Homesley HD
    N C Med J; 1982 Nov; 43(11):771-3. PubMed ID: 6817144
    [No Abstract]   [Full Text] [Related]  

  • 18. Pap smear provision in general practice.
    London L; Mackenzie I
    S Afr Med J; 1993 Feb; 83(2):138-9. PubMed ID: 8466577
    [No Abstract]   [Full Text] [Related]  

  • 19. Whatever happened to the annual pap smear?
    Vigliani MB
    R I Med J (2013); 2013 Jan; 96(1):36-8. PubMed ID: 23638458
    [No Abstract]   [Full Text] [Related]  

  • 20. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.
    Levin CE; Sellors JW
    Cancer; 2002 Apr; 94(8):2312-4; author reply 2314-6. PubMed ID: 12001136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.